1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with thrombin receptor peptide (42-55) in 1 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (thrombin receptor peptide (42-55)) | Trials (thrombin receptor peptide (42-55)) | Recent Studies (post-2010) (thrombin receptor peptide (42-55)) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 99 | 4 | 3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maruyama, I; Maruyama, Y; Soejima, Y | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and thrombin receptor peptide (42-55)
| Article | Year |
|---|---|
Thrombin receptor agonist peptide decreases thrombomodulin activity in cultured human umbilical vein endothelial cells.
Topics: Amino Acid Sequence; Cells, Cultured; Endothelium, Vascular; Epoprostenol; Humans; Kinetics; Molecular Sequence Data; Peptide Fragments; Plasminogen Activator Inhibitor 1; Platelet Activating Factor; Receptors, Cell Surface; Receptors, Thrombin; Thrombomodulin; Tissue Plasminogen Activator; Umbilical Veins; Vasoactive Intestinal Peptide | 1994 |